title: Inducible XIST-dependent X-chromosome inactivation in human somatic cells is reversible.
abstract: During embryogenesis, the XIST RNA is expressed from and localizes to one X chromosome in females and induces chromosome-wide silencing. Although many changes to inactive X heterochromatin are known, the functional relationships between different modifications are not well understood, and studies of the initiation of X-inactivation have been largely confined to mouse. We now present a model system for human XIST RNA function in which induction of an XIST cDNA in somatic cells results in localized XIST RNA and transcriptional silencing. Chromatin immunoprecipitation and immunohistochemistry shows that this silencing need only be accompanied by a subset of heterochromatic marks and that these can differ between integration sites. Surprisingly, silencing is XIST-dependent, remaining reversible over extended periods. Deletion analysis demonstrates that the first exon of human XIST is sufficient for both transcript localization and the induction of silencing and that, unlike the situation in mice, the conserved repeat region is essential for both functions. In addition to providing mechanistic insights into chromosome regulation and formation of facultative heterochromatin, this work provides a tractable model system for the study of chromosome silencing and suggests key differences from mouse embryonic X-inactivation.
authors.affiliation: Department of Medical Genetics, Molecular Epigenetics Group, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC, Canada.
authors.forename: Jennifer C
authors.initials: JC
authors.lastname: Chow
authors.forename: Lisa L
authors.initials: LL
authors.lastname: Hall
authors.forename: Sarah E L
authors.initials: SE
authors.lastname: Baldry
authors.forename: Nancy P
authors.initials: NP
authors.lastname: Thorogood
authors.forename: Jeanne B
authors.initials: JB
authors.lastname: Lawrence
authors.forename: Carolyn J
authors.initials: CJ
authors.lastname: Brown
mesh_terms: D047369:Chromatin Immunoprecipitation; D041321:Chromosomes, Human, X / Q000235:genetics* / Q000378:metabolism; D019175:DNA Methylation; D018076:DNA, Complementary; D004303:Dosage Compensation, Genetic; D004318:Doxycycline / Q000494:pharmacology; D005354:Fibrosarcoma / Q000473:pathology; D020868:Gene Silencing; D006570:Heterochromatin; D006657:Histones / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D008957:Models, Genetic; D062085:RNA, Long Noncoding; D022661:RNA, Untranslated; D017422:Sequence Analysis, DNA; D049951:X Chromosome Inactivation
chemical_list: D018076:DNA, Complementary; D006570:Heterochromatin; D006657:Histones; D062085:RNA, Long Noncoding; D022661:RNA, Untranslated; C077885:XIST non-coding RNA; D004318:Doxycycline